VuRoyal & Desert King International Event Agenda (March 20–23, 2024)

On March 20, 2024, vuRoyal and Desert King International will jointly organize the first QS-21 Forum in Shanghai, China. The day before the fifth Vaccine Innovation International Forum (VIF World 2024). The forum will bring together vaccine experts, researchers, business executives, policymakers and industry leaders from all over the world to jointly promote vaccine development and international cooperation.

As an important vaccine adjuvant, QS-21 has very broad usage and huge potential. vuRoyal and Desert King International have invited well-known international experts and scholars to participate in this forum to share the latest results in the field of QS-21. Together we will have an in-depth discussion of the research progress and broad usage of QS-21.

1. March 20: QS-21 Forum (Main Session)

13:00  : Attendee Registration

14:00–14:30  : Opening Remarks & Signing Ceremony

14:30–15:55  : Malaria Vaccine

Simon Draper (Professor of Vaccinology & Translational Medicine, University of Oxford)

14:55–15:05  : Q&A

15:05–15:30  : Key Quality Parameters of Particulate Adjuvants

Xu Yuhong 徐宇虹 (Professor & Doctoral Supervisor, Dali University)

15:30–15:40  : Q&A

15:40–15:55  : Tea Break

15:55–16:20  : QS21: Quality Research & Quality Control

Chen Dexiang 陈德祥 (GM, Chengdu Microcan Biotech Co., Ltd.)

16:20–16:30  : Q&A

16:30–16:55  : QS-21 for Advanced Adjuvants & Its Impact on Modern Vaccines (Plus DK Company Introduction)

Damian Hiley (Product Manager, Desert King International)

16:55–17:05  : Q&A

17:05–17:30  : Revolutionizing Vaccine Efficacy: The Strategic Role of QS-21

Wang Hao (CEO, VuRoyal Pharmaceuticals)

2. March 21 : VIF 5th Vaccine Innovation Forum 

VuRoyal Pharmaceuticals Booth (A4) & Lecture Hall H

11:30–12:00  : Advancing Global Health Through Vaccines

Simon Draper (Professor, University of Oxford) & Wang Hao

3. March 22 : VIF 5th Vaccine Innovation Forum

VuRoyal Pharmaceuticals Booth (A4) & Lecture Hall H

13:30–14:00  : QS-21 for Advanced Adjuvants & Its Impact on Modern Vaccines

Wang Hao (CEO, VuRoyal) & Damian Hiley (Product Manager, Desert King)

4. March 23 : VIF 5th Vaccine Innovation Forum

VuRoyal Pharmaceuticals Booth (A4)

* Notes: All times are in Beijing Time (UTC+8).